ADIAL PHARMACEUTICALS, INC. Contracts & Agreements

Amended and Restated Employment Agreement between Adial Pharmaceuticals, Inc. and Cary J. Claiborne, effective as of December 5, 2024 (Filed With SEC on December 6, 2024)

Amendment No. 6 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on November 12, 2024)

Separation Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated November 1, 2024 (Filed With SEC on November 5, 2024)

Employment Agreement between Adial Pharmaceuticals, Inc. and Vinah Shah, dated November 1, 2024 (Filed With SEC on November 5, 2024)

Separation Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated April 22, 2024 (Filed With SEC on April 26, 2024)

At the Market Offering Agreement, dated April 18, 2024, by and between Adial Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 18, 2024)

Form of New Warrant (Filed With SEC on March 6, 2024)

Form of Placement Agent Warrant (Filed With SEC on March 6, 2024)

Form of Warrant Inducement Agreement by and between Adial Pharmaceuticals, Inc. and Holder (Filed With SEC on March 6, 2024)

Statement of Work #2, dated January 17, 2024, to Master Services Agreement between Adial Pharmaceuticals, Inc. and The Keswick Group, LLC, dated March 15, 2023 (Filed With SEC on January 18, 2024)

Amendment No. 5 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on November 6, 2023)

Form of Pre-Funded Warrant (Filed With SEC on October 24, 2023)

Form of Series A Purchase Warrant (Filed With SEC on October 24, 2023)

Form of Series B Purchase Warrant (Filed With SEC on October 24, 2023)

Form of Placement Agent Warrant (Filed With SEC on October 24, 2023)

Form of Securities Purchase Agreement, dated October 19, 2023, by and between Adial Pharmaceuticals, Inc. and the Purchaser signatory thereto (Filed With SEC on October 24, 2023)

Form of Registration Rights Agreement, dated October 19, 2023, by and between Adial Pharmaceuticals, Inc. and the Purchaser signatory thereto (Filed With SEC on October 24, 2023)

Final Acquisition Agreement, dated September 18, 2023, by and between Adovate LLC and Adial Pharmaceuticals, Inc (Filed With SEC on September 21, 2023)

Purchase Agreement, dated as of May 31, 2023, by and between Adial Pharmaceuticals, Inc. and Alumni Capital LP (Filed With SEC on June 2, 2023)

Option Exercise Agreement, dated May 8, 2023, by and between Adovate LLC and Adial Pharmaceuticals, Inc (Filed With SEC on May 10, 2023)

Master Services Agreement between Adial Pharmaceuticals, Inc. and The Keswick Group, LLC, dated March 15, 2023 (Filed With SEC on March 21, 2023)

Form of Placement Agent Warrant (Filed With SEC on February 24, 2023)

Form of Securities Purchase Agreement (Filed With SEC on February 24, 2023)

Placement Agency Agreement (Filed With SEC on February 24, 2023)

Form of Voting Agreement (Filed With SEC on February 24, 2023)

Option Agreement for the Acquisition of Purnovate, Inc. by Adenomed, LLC dated as of January 27, 2023 (Filed With SEC on February 1, 2023)

Amendment 6 to Employment Agreement effective as of the January 27, 2023 by and between Adial Pharmaceuticals, Inc. and William B. Stilley, III (Filed With SEC on February 1, 2023)

Amendment No. 4 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on October 13, 2022)

Amendment, dated September 8, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole A. Johnson, dated March 24, 2019, as amended on March 22, 2022 (Filed With SEC on September 13, 2022)

Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and Cary J. Claiborne (Filed With SEC on August 23, 2022)

Amendment to Employment Agreement, dated as of August 22, 2022, between Adial Pharmaceuticals, Inc. and William B. Stilley (Filed With SEC on August 23, 2022)

Amendment, dated March 22, 2022, to Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019 (Filed With SEC on March 28, 2022)

Form of Pre-Funded Warrant (Filed With SEC on February 14, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on February 14, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 14, 2022)

Placement Agency Agreement (Filed With SEC on February 14, 2022)

Employment Agreement between Adial Pharmaceuticals, Inc. and Cary Claiborne, dated as of December 7, 2021 (Filed With SEC on December 9, 2021)

Form of Stock Purchase Agreement (Filed With SEC on November 12, 2021)

Form of Registration Rights Agreement (Filed With SEC on November 12, 2021)

Amendment No. 3 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on September 29, 2021)

Form of Stock Purchase Agreement (Filed With SEC on July 9, 2021)

Form of Registration Rights Agreement (Filed With SEC on July 9, 2021)

Form of Underwriting Agreement (Filed With SEC on June 23, 2021)

Lockup Agreement Extension executed Dr. Bankole Johnson, dated April 5, 2021 (Filed With SEC on April 9, 2021)

Description of Securities (Filed With SEC on March 22, 2021)

Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of February 12, 2021 (Filed With SEC on March 22, 2021)

Amendment to Executive Employment Agreement with Joseph Truluck, effective as of February 12, 2021 (Filed With SEC on March 22, 2021)

Amendment to Executive Employment Agreement with William B. Stilley, III, effective as of March 17, 2021 (Filed With SEC on March 22, 2021)

Form of Securities Purchase Agreement (Filed With SEC on March 15, 2021)

Form of Registration Rights Agreement (Filed With SEC on March 15, 2021)

Amendment, dated January 25, 2021, by and among Adial Pharmaceuticals, Inc., Purnovate, Inc., a wholly owned subsidiary of Adial, PNV Conversion Corp. as successor-in interest to... (Filed With SEC on February 1, 2021)

Offer Letter, dated December 14, 2020 (Filed With SEC on December 17, 2020)

Equity Purchase Agreement, dated December 7, 2020, by and among Adial Pharmaceuticals, Inc., Purnovate, LLC, the members of Purnovate, LLC and Robert D. Thompson, as member... (Filed With SEC on December 10, 2020)

Common Stock Purchase Agreement, dated as of November 18, 2020, by and between Adial Pharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on November 24, 2020)

Registration Rights Agreement, dated as of November 18, 2020, by and between Adial Pharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on November 24, 2020)

Lock-Up Agreement Extension and Right of First Refusal dated August 19, 2020 to Lock-Up Agreement (Filed With SEC on August 25, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on June 12, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on June 10, 2020)

Placement Agency Agreement, dated June 9, 2020, by and among Adial Pharmaceuticals, Inc. and Maxim Group LLC and Joseph Gunnar & Co., LLC (Filed With SEC on June 10, 2020)

Form of Securities Purchase Agreement, dated as of June 9, 2020, by and among Adial Pharmaceuticals, Inc. and the Investors (Filed With SEC on June 10, 2020)

Description of Securities (Filed With SEC on March 20, 2020)

Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 3, 2020 (Filed With SEC on March 6, 2020)

Amendment 7 to License Agreement by and between the University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group and Adial... (Filed With SEC on December 31, 2019)

Amendment to Statement of Work under Master Services Agreement dated December 12, 2019, by and between Adial Pharmaceuticals, Inc. and Psychological Education Publishing Company (Filed With SEC on December 16, 2019)

Guaranty, dated December 12, 2019, executed by Dr. Bankole Johnson (Filed With SEC on December 16, 2019)

Pledge and Security Agreement, dated December 12, 2019 (Filed With SEC on December 16, 2019)

Lock-Up Agreement, dated December 12, 2019 (Filed With SEC on December 16, 2019)

Master Services Agreement and related statement of work, dated July 5, 2019, by and between Adial Pharmaceuticals, Inc. and Psychological Education Publishing Company (Filed With SEC on July 8, 2019)

Consulting Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated March 24, 2019 (Filed With SEC on March 26, 2019)

Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and William Stilley, dated as of March 11, 2019 (Filed With SEC on March 14, 2019)

Amendment to Employment Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated as of March 11, 2019 (Filed With SEC on March 14, 2019)

Underwriting Agreement, dated February 21, 2019, by and among Adial Pharmaceuticals, Inc., Maxim Group LLC and Joseph Gunnar & Co., LLC (Filed With SEC on February 26, 2019)

Form of Warrant (Filed With SEC on February 26, 2019)

Form of Warrant Agency Agreement dated February 25, 2019 between Adial Pharmaceuticals, Inc. and VStock Transfer, LLC (Filed With SEC on February 26, 2019)

Form of Underwriting Agreement (Filed With SEC on February 19, 2019)

Form of Common Stock Warrant (Filed With SEC on February 19, 2019)

Form of Underwriting Agreement (Filed With SEC on February 12, 2019)

Form of Common Stock Warrant (Filed With SEC on February 12, 2019)

Form of Warrant Agency Agreement (Filed With SEC on February 12, 2019)

Amendment No. 6 to License Agreement between the Company, University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group dated as of... (Filed With SEC on December 19, 2018)

Form of Exchange Agreement, dated November 12, 2018 (Filed With SEC on November 14, 2018)

Form of $5.00 Warrant to purchase common stock, dated November 12, 2018 (Filed With SEC on November 14, 2018)

Form of $6.25 Warrant to purchase common stock, dated November 12, 2018 (Filed With SEC on November 14, 2018)

Form of Unit Warrant (Filed With SEC on September 10, 2018)

Form of Underwriting Agreement (Filed With SEC on June 11, 2018)

Warrant to purchase 300,000 shares of Common Stock issued June 6, 2018 (Filed With SEC on June 11, 2018)

Form of Warrant Agent Agreement (Filed With SEC on June 11, 2018)

Form of Warrant (Filed With SEC on June 11, 2018)

Note issued on June 6, 2018 in the principal amount of $325,000 (Filed With SEC on June 11, 2018)

Amendment No. 1 to 18% Senior Secured Promissory Note (Filed With SEC on June 11, 2018)

Securities Purchase Agreement dated June 6, 2018 (Filed With SEC on June 11, 2018)

Security Agreement dated June 6, 2018 (Filed With SEC on June 11, 2018)

Grant Incentive Plan (Filed With SEC on April 16, 2018)

Form of Senior Secured Promissory Note dated March 1, 2018 by and between Adial Pharmaceuticals, Inc. and certain investors (Filed With SEC on April 16, 2018)

Form of Security Agreement by and between Adial Pharmaceuticals, Inc. and certain investors (Filed With SEC on April 16, 2018)

Form of Common Stock Purchase Warrant by and between Adial Pharmaceuticals, Inc. certain investors (Filed With SEC on April 16, 2018)

Form of Common Stock Purchase Warrant by and among Adial Pharmaceuticals, Inc. and consultant (Filed With SEC on April 16, 2018)

Amendment #5 to License Agreement between University of Virginia Patent Foundation and Adial Pharmaceuticals, Inc., dated as of December 14, 2017 (Filed With SEC on April 16, 2018)

Form of Securities Purchase Agreement by and among Adial Pharmaceuticals, Inc. and certain investors (Filed With SEC on April 16, 2018)

Backstop Commitment Agreement between Adial Pharmaceuticals, Inc. and MVA 151 Investors LLC dated February 22, 2018 (Filed With SEC on April 16, 2018)

Medical Translation Services Agreement by and between Adial Pharmaceuticals, Inc. and Medico-Trans Company, LLC dated January 29, 2018 (Filed With SEC on April 16, 2018)

Amendment to Consulting Agreement with Joseph Truluck dated December 1, 2017 (Filed With SEC on April 16, 2018)

Performance Bonus Plan Cancellation (Filed With SEC on April 16, 2018)

Settlement Agreement dated as of February 22, 2018 by and between ADial Pharmaceuticals, Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on April 16, 2018)

UNDERWRITINGAGREEMENT between ADIALPHARMACEUTICALS, INC., and JOSEPHGUNNAR & CO., LLC asRepresentative of the Several Underwriters (Filed With SEC on November 22, 2017)

WARRANTTO PURCHASE COMMON STOCK ADIALPHARMACEUTICALS, INC. (Filed With SEC on November 22, 2017)

Amendment No. 2 to Senior Secured Promissory Note dated as of November 21, 2017 by and between ADial Pharmaceuticals, L.L.C. as predecessor-in-interest to Adial Pharmaceuticals,... (Filed With SEC on November 22, 2017)

FORMOF SENIOR SECURED PROMISSORY NOTE (Filed With SEC on November 22, 2017)

FORMOF COMMON STOCK PURCHASE AGREEMENT ADIALPHARMACEUTICALS, INC. (Filed With SEC on November 22, 2017)

FORMOF SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2017)

FORMOF SECURITY AGREEMENT (Filed With SEC on November 22, 2017)

Form of Underwriting Agreement (Filed With SEC on October 25, 2017)

Specimen Common Stock Certificate (Filed With SEC on October 25, 2017)

Amendment to Senior Secured Promissory Note dated as of October 23, 2017 by and between ADial Pharmaceuticals, L.L.C. as predecessor-in-interest to Adial Pharmaceuticals, Inc. and... (Filed With SEC on October 25, 2017)

Form of Underwriting Agreement (Filed With SEC on September 7, 2017)

Form of Representatives Warrant Agreement (Filed With SEC on September 7, 2017)

Form of Warrant to Purchase Membership Units (2011 Offering) (Filed With SEC on September 7, 2017)

Form of Warrant to Purchase Membership Units (2013 Offering) (Filed With SEC on September 7, 2017)

Form of Common Stock Purchase Warrant by and between ADial Pharmaceuticals, LLC and FirstFire Global Opportunities Fund, LLC (Filed With SEC on September 7, 2017)

Form of 2016 Convertible Promissory Note (2016 Offering) (Filed With SEC on September 7, 2017)

Senior Secured Promissory Note dated as of May 1, 2017 by and between ADial Pharmaceuticals, LLC and FirstFire Global Opportunities Fund, LLC (Filed With SEC on September 7, 2017)

Form of Membership Unit Award (Profits Interest) Agreement (Filed With SEC on September 7, 2017)

Option Agreement between ADial Pharmaceuticals, LLC and Tony Goodman, effective July 1, 2017 (Filed With SEC on September 7, 2017)

Performance Bonus Plan dated April 15, 2017 (Filed With SEC on September 7, 2017)

Form of Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on September 7, 2017)

Form of Stock Option Grant Notice, Option Agreement (Incentive Stock Option or Nonstatutory Stock Option) and Notice of Exercise under the 2017 Equity Incentive Plan (Filed With SEC on September 7, 2017)

Form of ADial Pharmaceuticals, LLC Option Agreement (Filed With SEC on September 7, 2017)

License Agreement between the University of Virginia Patent Foundation and ADial Pharmaceuticals, L.L.C. effective January 21, 2011 (Filed With SEC on September 7, 2017)

Amendment #1 to License Agreement between University of Virginia Patent Foundation and ADial Pharmaceuticals, LLC effective October 21, 2013 (Filed With SEC on September 7, 2017)

Amendment #2 to License Agreement between University of Virginia Patent Foundation and ADial Pharmaceuticals, LLC effective May 18, 2016 (Filed With SEC on September 7, 2017)

Amendment #3 to License Agreement between University of Virginia Patent Foundation and ADial Pharmaceuticals, LLC effective March 27, 2017 (Filed With SEC on September 7, 2017)

Executive Employment Agreement with William B. Stilley, III dated December 6, 2010 (Filed With SEC on September 7, 2017)

Salary Forbearance Agreement with William B. Stilley, III dated August 17, 2016 (Filed With SEC on September 7, 2017)

Consulting Agreement with Joseph Truluck dated April 25, 2016 (Filed With SEC on September 7, 2017)

Termination Agreement with Cato Holding Company dated March 14, 2016 (Filed With SEC on September 7, 2017)

Securities Purchase Agreement dated as of May 1, 2017 by and between ADial Pharmaceuticals, LLC and FirstFire Global Opportunities Fund, LLC (Filed With SEC on September 7, 2017)

Security Agreement dated May 1, 2017 by and between ADial Pharmaceuticals, LLC and FirstFire Global Opportunities Fund, LLC (Filed With SEC on September 7, 2017)

Settlement Agreement and Release of Claims entered into as of January 25, 2016 by and between Bankole Johnson and ADial Pharmaceuticals, LLC (Filed With SEC on September 7, 2017)

Promissory Note issued to ADial Pharmaceuticals, L.L.C. by Bankole A. Johnson in the principal amount of $35,000, dated November 24, 2016 (Filed With SEC on September 7, 2017)

Form of Subscription Agreement to the Offering of Class B Units (Filed With SEC on September 7, 2017)

Consulting Agreement between ADial Pharmaceuticals, LLC and Crescendo Communications, LLC Agreed to and approved June 30, 2017 (Filed With SEC on September 7, 2017)

Form of Employment Agreement to be entered into with William B. Stilley, III (Filed With SEC on September 7, 2017)

Form of Employment Agreement to be entered into with Joseph A. M. Truluck (Filed With SEC on September 7, 2017)

Form of Employment Agreement to be entered into with Tomasz H. Zastawny, Ph.D (Filed With SEC on September 7, 2017)

Form of Indemnification Agreement (Filed With SEC on September 7, 2017)

Sublease Agreement with Inspyr Therapeutics, Inc. dated August 16, 2017 (Filed With SEC on September 7, 2017)

Amendment #4 to License Agreement between University of Virginia Patent Foundation and ADial Pharmaceuticals, LLC effective August 15, 2017 (Filed With SEC on September 7, 2017)

Category

Industry

Companies

Contracts

ADIAL PHARMACEUTICALS, INC. Contracts & Agreements